|FOR IMMEDIATE RELEASE
Thursday, February 17, 2005
Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
||The National Institutes of Health will host “Advances
in Uterine Leiomyoma Research: 2nd NIH International Congress” on
February 24-25. This conference will bring together researchers
working in the fields of biomedicine, epidemiology, basic
research, therapeutics, and translational medicine to foster
an exchange of scientific information among members of
the uterine leiomyoma (fibroids) research and health care
communities. Fibroids are the most common gynecologic neoplasm
in women of reproductive age and the leading cause of hysterectomy
in the United States. Topics to be covered include Clinical
Experiences and Therapeutic Strategies, Epidemiology, Clinical
Trials, Pathogenesis of Smooth Muscle Tumors, and Molecular
and Genetics Characteristics.
Thursday, February 24, 2005, 8:00 a.m. - 5:00 p.m.
and Friday, February 25, 2005, 8:00 a.m. - 5:30 p.m.
||Natcher Conference Center, National Institutes of Health
Bethesda, Maryland 20892
||This conference will be co-chaired by Dr. Vivian Pinn,
Associate Director for Women’s Health and Director,
Office of Research on Women’s Health (ORWH), NIH
and Dr. Kenneth Olden, Director, National Institute of
Environmental Health Sciences, NIH. Program co-chairs include
Dr. J. Carl Barrett, National Cancer Institute (NCI), Drs.
Estella Parrott and James Segars, National Institute of
Child Health and Human Development (NICHD), Dr. Barbara
J. Davis, AstraZeneca, and Darlene Dixon, National Institute
of Environmental Health Sciences (NIEHS). Participants
will represent academia, medical centers, government, industry,
|Note to Editors:
||This congress is a joint effort within the Department
of Health and Human Services, including the NIH ORWH, NIEHS,
NICHD, NCI, National Institute of Biomedical Imaging
and Bioengineering (NIBIB), National Center for Research
Resources (NCRR), and the
following DHHS entities: Agency for Healthcare Research
and Quality (AHRQ), Centers for Disease Control and Prevention
(CDC), Food and Drug Administration (FDA), Health Research
and Services Administration (HRSA), Office of Women’s
Health, Office of the Secretary (OWH), and the Substance
Abuse and Mental Health Services Administration (SAMSHA).
For more information or to register, please visit http://www4.od.nih.gov/orwh/
or call (301) 402-1770.
Note: this news release was amended on February 23, 2005 to include the hours of the event.